title: Eruptive pseudoangiomatosis in a child undergoing chemotherapy for Hodgkin lymphoma.
authors.forename: Meret
authors.initials: M
authors.lastname: Henry
authors.forename: Süreyya
authors.initials: S
authors.lastname: Savaşan
mesh_terms: D000293:Adolescent; D000798:Angiomatosis / Q000139:chemically induced* / Q000175:diagnosis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001761:Bleomycin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis; D017445:Skin Diseases, Vascular / Q000139:chemically induced* / Q000175:diagnosis; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone